Statistics for Basilea Pharmaceutica AG (id:13109 BSLN)

Valuation metrics

Market cap

482.42M

Enterprise value

531.90M

Trailing P/E (ttm)

53.08

Forward P/E

11.12

PEG ratio

11.12

Price/Sales (ttm)

3.24

Price/Book (mrq)

28.74

Enterprise Value/Revenue

3.57

Enterprise Value/EBITDA

-95.04

Overview

Shares outstanding

12.12M

Float

12.11M

Shares short

% Held by insiders

0.00%

% Held by institutions

0.33%

Average volume (10 days)

27.18K

Average volume (90 days)

Price summary

52-Week low

32.00

52-Week high

47.95

52-Week change

12.70%

Beta

0.74

50-Day moving average

44.47

200-Day moving average

41.24

Dividends and splits

Forward annual dividend rate

20.00

Forward annual dividend yield

0.49

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

April 11th, 2013

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

-0.44%

Operating margin

12.47%

Operational effectiveness

Return on assets

-2.05%

Return on equity

-4.10%

Income statement

Revenue (ttm)

12.37

Revenue per share (ttm)

12.37

Quarterly revenue growth (yoy)

-0.35

Gross profit (ttm)

130.84M

EBITDA

23.24M

Net income to common (ttm)

-652,000.00

Diluted EPS (ttm)

-0.07

Quarterly earnings growth (yoy)

-34.90%

Balance sheet

Total cash (mrq)

62.96M

Total cash per share (mrq)

5.19

Total debt (mrq)

112.45M

Total Debt/Equity (mrq)

669.89

Current ratio (mrq)

410.30%

Book value per share (mrq)

1.38

Cash flow

Cash flow statement

10.30M

Levered free cash flow (LFCF)

13.88M